484 related articles for article (PubMed ID: 8650077)
1. Regulation of prostatic growth and function by peptide growth factors.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
[TBL] [Abstract][Full Text] [Related]
2. Peptide growth factors in the prostate as mediators of stromal epithelial interaction.
Byrne RL; Leung H; Neal DE
Br J Urol; 1996 May; 77(5):627-33. PubMed ID: 8689101
[TBL] [Abstract][Full Text] [Related]
3. [Peptide growth factors in the prostate].
Tatoud R; Desgrandchamps F; DeGeorges A; Thomas F
Pathol Biol (Paris); 1993 Oct; 41(8):731-40. PubMed ID: 7507232
[TBL] [Abstract][Full Text] [Related]
4. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
Giri D; Ropiquet F; Ittmann M
J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017
[TBL] [Abstract][Full Text] [Related]
5. [Benign prostatic hyperplasia and growth factors: mechanisms and hypotheses].
Aumüller G
Urologe A; 1992 May; 31(3):159-65. PubMed ID: 1377433
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
7. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
[TBL] [Abstract][Full Text] [Related]
8. Polypeptide modulators of prostatic growth and development.
Story MT
Cancer Surv; 1991; 11():123-46. PubMed ID: 1726787
[TBL] [Abstract][Full Text] [Related]
9. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.
Scher HI; Sarkis A; Reuter V; Cohen D; Netto G; Petrylak D; Lianes P; Fuks Z; Mendelsohn J; Cordon-Cardo C
Clin Cancer Res; 1995 May; 1(5):545-50. PubMed ID: 9816014
[TBL] [Abstract][Full Text] [Related]
10. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
Pavone-Macaluso M; Carruba G; Castagnetta L
Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
[TBL] [Abstract][Full Text] [Related]
11. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
12. An orthotopic model for the study of growth factors in the ventral prostate of the rat: effects of epidermal growth factor and basic fibroblast growth factor.
Marengo SR; Chung LW
J Androl; 1994; 15(4):277-86. PubMed ID: 7982795
[TBL] [Abstract][Full Text] [Related]
13. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
Myers RB; Kudlow JE; Grizzle WE
Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115
[TBL] [Abstract][Full Text] [Related]
14. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
15. Benign prostatic hyperplasia and growth factors.
Lawson RK
Urologe A; 1990 Jan; 29(1):5-7. PubMed ID: 1690485
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
Liu C; Tsao MS; Grisham JW
Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
[TBL] [Abstract][Full Text] [Related]
20. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
